Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Treasury Shares (2017 - 2025)

Historic Treasury Shares for Niagen Bioscience (NAGE) over the last 9 years, with Q3 2025 value amounting to $1.5 million.

  • Niagen Bioscience's Treasury Shares rose 12207.6% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 12207.6%. This contributed to the annual value of $609000.0 for FY2024, which is 339.56% up from last year.
  • As of Q3 2025, Niagen Bioscience's Treasury Shares stood at $1.5 million, which was up 12207.6% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Treasury Shares registered a high of $1.5 million during Q1 2025, and its lowest value of $589000.0 during Q4 2023.
  • Moreover, its 4-year median value for Treasury Shares was $774000.0 (2023), whereas its average is $928909.1.
  • As far as peak fluctuations go, Niagen Bioscience's Treasury Shares plummeted by 938.46% in 2023, and later soared by 12207.6% in 2025.
  • Niagen Bioscience's Treasury Shares (Quarter) stood at $650000.0 in 2022, then fell by 9.38% to $589000.0 in 2023, then increased by 3.4% to $609000.0 in 2024, then soared by 149.43% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.5 million for Q2 2025, and $1.5 million during Q1 2025.